Cyclopharm Stock

Cyclopharm ROCE 2025

Cyclopharm ROCE

-0.34

Ticker

CYC.AX

ISIN

AU000000CYC5

In 2025, Cyclopharm's return on capital employed (ROCE) was -0.34, a 27.46% increase from the -0.27 ROCE in the previous year.

Cyclopharm Aktienanalyse

What does Cyclopharm do?

Cyclopharm Ltd is an Australian company that was founded in 1986 and has since been developing innovative medical solutions. The company operates in the field of nuclear medicine and focuses on providing diagnostic and therapeutic products and services. The history of Cyclopharm Ltd began with the development of the Technetium-99m generator, an instrument for generating radioisotopes that can be used in medical imaging. Since then, the company has expanded its offerings and now offers a wide range of products and services. Cyclopharm Ltd's business model is based on research and development of new solutions based on the needs of the medical community and patients. The company works closely with doctors, scientists, and other experts to ensure that its products and services meet the highest standards. Cyclopharm Ltd is divided into various divisions to coordinate and optimize its activities. These include diagnostics, therapy, research and development, as well as sales and marketing. Each division works closely with the others to ensure that the company achieves its goals and provides optimal customer care. Some of Cyclopharm Ltd's most well-known products include the Technetium-99m generator and the radiopharmaceutical Technegas. Technegas is a gas used for lung imaging and plays an important role in diagnosing lung problems. The radiopharmaceutical is produced using the Technetium-99m generator and is an important addition to medical imaging. In addition, Cyclopharm Ltd also develops therapeutic solutions that can be used to treat cancer and other diseases. These include radiopharmaceuticals used in radiation therapy, as well as other solutions tailored to the individual needs of patients. Cyclopharm Ltd is also actively working on improving and expanding its products and services. The company invests in research and development to develop innovative solutions that can improve medical imaging and therapy. Additionally, the company works closely with its customers to better understand their needs and offer them tailored solutions. Overall, Cyclopharm Ltd is an innovative and goal-oriented company that focuses on providing diagnostic and therapeutic solutions in the field of nuclear medicine. The company has a long history of leadership in this field and will continue to be at the forefront of developing solutions that improve the lives of patients and medical professionals. Cyclopharm ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Cyclopharm's Return on Capital Employed (ROCE)

Cyclopharm's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Cyclopharm's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Cyclopharm's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Cyclopharm’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Cyclopharm stock

What is the ROCE (Return on Capital Employed) of Cyclopharm this year?

The ROCE of Cyclopharm is -0.34 undefined this year.

How has the ROCE (Return on Capital Employed) of Cyclopharm developed compared to the previous year?

The ROCE of Cyclopharm has increased by 27.46% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Cyclopharm?

A high Return on Capital Employed (ROCE) indicates that Cyclopharm has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Cyclopharm?

A low ROCE (Return on Capital Employed) can indicate that Cyclopharm has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Cyclopharm impact the company?

An increase in the ROCE of Cyclopharm can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Cyclopharm affect the company?

A decrease in ROCE of Cyclopharm can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Cyclopharm?

Some factors that can affect Cyclopharm's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Cyclopharm so important for investors?

The ROCE of Cyclopharm is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Cyclopharm take to improve the ROCE?

To improve the ROCE, Cyclopharm can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Cyclopharm pay?

Over the past 12 months, Cyclopharm paid a dividend of 0.01 AUD . This corresponds to a dividend yield of about 0.94 %. For the coming 12 months, Cyclopharm is expected to pay a dividend of 0.05 AUD.

What is the dividend yield of Cyclopharm?

The current dividend yield of Cyclopharm is 0.94 %.

When does Cyclopharm pay dividends?

Cyclopharm pays a quarterly dividend. This is distributed in the months of May, October, April, October.

How secure is the dividend of Cyclopharm?

Cyclopharm paid dividends every year for the past 3 years.

What is the dividend of Cyclopharm?

For the upcoming 12 months, dividends amounting to 0.05 AUD are expected. This corresponds to a dividend yield of 4.95 %.

In which sector is Cyclopharm located?

Cyclopharm is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cyclopharm kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cyclopharm from 9/11/2023 amounting to 0.005 AUD, you needed to have the stock in your portfolio before the ex-date on 9/1/2023.

When did Cyclopharm pay the last dividend?

The last dividend was paid out on 9/11/2023.

What was the dividend of Cyclopharm in the year 2024?

In the year 2024, Cyclopharm distributed 0.01 AUD as dividends.

In which currency does Cyclopharm pay out the dividend?

The dividends of Cyclopharm are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cyclopharm

Our stock analysis for Cyclopharm Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cyclopharm Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.